Bacteriostatic Water · Research brief

Where to Buy Dihexa — Purity, COAs, Supplier Checks

Real Peptides Research TeamEditorial

Updated December 1, 20259 min read

59 WORDS

Short answer

Dihexa is one of the few research compounds where the solvent and the shipping matter as much as the synthesis. It is intensely lipophilic by design, which makes it awkward to dissolve, impossible to judge by eye, and easy for a low-grade vendor to misrepresent. So before you buy dihexa, the useful question isn't which site has it listed.

Key takeaways

Dihexa is not an FDA-approved drug and cannot be obtained from a pharmacy; it is sold only as a research-use-only chemical.
The single most important thing to verify before you buy dihexa is a lot-specific certificate of analysis with an HPLC chromatogram and a mass spectrometry identity confirmation.
Research-grade specifications for this compound are normally 98% purity or higher, and a supplier that states purity without showing the instrument trace has proven nothing.
Dihexa is highly lipophilic and will not dissolve properly in bacteriostatic water, so researchers document an organic co-solvent system instead.
Lyophilized material is stored at −20°C or colder, while prepared stock solutions are refrigerated at 2–8°C and aliquoted to avoid repeated freeze-thaw cycles.
Pre-mixed solutions, topical bases and sublingual preparations are consumer-facing formats that make analytical verification impossible, which is reason enough to skip them.

We synthesise and document research peptides in small batches, and we field this exact problem constantly from labs that buy dihexa for the first time. The pattern rarely varies: the material arrives, it won't go into water, and nobody can produce paperwork tied to the lot number printed on the label.

Where can you buy dihexa?

Dihexa is available only as a research-use-only chemical from peptide supply companies, not from pharmacies, because it is not an FDA-approved drug. Researchers buy dihexa as a lyophilized powder, commonly in 5 mg or 10 mg vials, and should require a lot-specific COA showing HPLC purity of at least 98% plus mass spectrometry identity confirmation.

The oversimplification worth killing: a polished storefront listing dihexa tells you nothing about the material inside the vial, because nobody is auditing that listing. There is no approved pharmaceutical version of this compound to benchmark against, which makes the certificate of analysis the only identity evidence that exists. This article covers what you're actually ordering, how to vet a supplier before you buy dihexa, and the storage and solubility failures that ruin more research-grade material than contamination ever does.

What you are actually ordering when you source dihexa

Dihexa, described in the literature as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide and also catalogued as PNB-0408, is a small lipophilic peptidomimetic derived from angiotensin IV research carried out at Washington State University. Published preclinical work describes it as acting through hepatocyte growth factor (HGF) and its receptor c-Met, a signalling pair that research links to dendritic spine formation and synaptogenesis in rodent models. That same research lineage produced the programme commercialised by M3 Biotechnology, which later became Athira Pharma and carried an HGF/MET candidate into clinical trials. The material sold to laboratories is not that clinical candidate.

Two facts shape every purchasing decision. First, dihexa is not an FDA-approved drug, has no approved human product to compare against, and is supplied strictly for laboratory research. Second, it is a peptidomimetic rather than a straightforward peptide chain, so identity confirmation depends on mass spectrometry rather than a simple sequence readout.

Most researchers buy dihexa as a lyophilized powder in sealed glass vials, typically at 5 mg or 10 mg fill weights. Some vendors also list pre-dissolved solutions, transdermal bases, or sublingual preparations. Those formats should make any research buyer uneasy. An undisclosed solvent system paired with an undisclosed concentration makes downstream measurement meaningless, and it signals a vendor selling to consumers rather than to laboratories. In our experience fielding sourcing questions, the vendors most eager to skip the powder step are the same ones least able to produce a chromatogram when asked.

What to check before you buy dihexa from any supplier

The only document that matters is a lot-specific certificate of analysis, and the clearest sign of a weak supplier is a COA that isn't tied to the vial in your hand. A legitimate report names the analytical method, carries a batch or lot number matching the label, shows a test date close to your fill date, and includes both an HPLC chromatogram for purity (research-grade material is normally specified at 98% or higher) and a mass spectrometry result confirming molecular identity.

Here's the part most sourcing guides miss. Plenty of vendors publish one COA for dihexa and reuse it across every batch for years. The giveaways are consistent: a chromatogram with the lot number cropped out, a report dated well before the storefront existed, or a purity figure printed as marketing text with no instrument trace behind it. Ask for the raw report for your lot specifically. Suppliers running genuine small-batch synthesis generate one per batch as a matter of routine, which is why we maintain a published COA library instead of a single specimen document.

Beyond paperwork, three things separate serviceable suppliers from the rest when you buy dihexa: disclosed storage and shipping conditions, research-use-only labelling with no dosing or administration guidance anywhere on the site, and a contactable person who can answer an analytical question. Any vendor that volunteers a human protocol has already told you what kind of operation it is. Labs that buy dihexa repeatedly tend to consolidate with one supplier for exactly this reason. Batch-to-batch consistency is only measurable if the documentation is consistent too.

Storage, solvents and the solubility problem nobody warns you about

Dihexa was engineered for lipophilicity so it could cross the blood brain barrier in animal models, and that same property makes it stubbornly insoluble in water. This is the most common surprise for researchers who buy dihexa for the first time: bacteriostatic water, the default reconstitution fluid for hydrophilic research peptides, will not properly dissolve it. Researchers working with the compound typically prepare stock solutions using an organic co-solvent such as DMSO or ethanol, then record that solvent system, because the vehicle changes how any result can be interpreted.

Neutral arithmetic keeps the records honest. A vial containing 10 mg of powder brought up to 2 mL of solvent yields a 5 mg/mL stock; the same 10 mg in 5 mL yields 2 mg/mL. The certificate is where you confirm the actual fill weight before doing that maths, since an underfilled vial silently shifts every concentration calculated from it.

Handling rules are unglamorous and non-negotiable. Lyophilized material holds best at −20°C or colder, sealed, dry, and protected from light. Stock solutions belong at 2–8°C, aliquoted into single-use volumes to avoid repeated freeze-thaw cycles, labelled with solvent, concentration and date. Everything here is laboratory handling and procurement education for research settings, not guidance for use in people or animals. Labs that buy dihexa without a cold storage plan lose material to degradation long before they lose it to contamination, and degraded peptidomimetic looks exactly like intact peptidomimetic sitting in a vial.

Dihexa sourcing channels compared

Where you buy dihexa changes what documentation you get, not just what you pay. The table below compares the four channels research buyers actually encounter.

Sourcing channel	Documentation you can expect	Identity and purity verification	Practical risk	Bottom line
Domestic research-supply companies using small-batch synthesis	Lot-numbered COA per batch, HPLC chromatogram, mass spectrometry report	Analytical report traceable to the specific vial shipped, with method and test date stated	Higher cost per mg than bulk offers, and stock arrives in batch cycles	Best fit for work that has to be reproducible, because the paperwork follows your individual lot
Overseas bulk manufacturers and open marketplaces	Frequently a single generic COA reused across listings, sometimes undated	Rarely traceable to the lot shipped; chromatograms often cropped or illegible	Customs holds, weeks of ambient-temperature transit, inconsistent fill weights	Only workable if you independently assay every shipment, which erases the savings
Wellness and anti-aging resellers offering pre-mixed solutions	Marketing copy, occasional purity claim with no instrument trace	Solvent identity and concentration usually undisclosed	Pre-solubilized product blurs research-use-only lines and degrades unpredictably	Avoid for research: an undocumented vehicle makes every downstream measurement uninterpretable
Large chemical catalog houses	Full analytical packet plus safety data sheet	Strong, with published specifications and documented methods	Institutional accounts, order minimums, long lead times, premium pricing	Excellent documentation if your institution can purchase this way and absorb the wait

What If: Dihexa Sourcing Scenarios

What if the dihexa powder will not dissolve in bacteriostatic water?

Stop adding water and switch to a documented co-solvent approach rather than heating or shaking the vial harder. The compound's lipophilicity is a designed feature, not a defect in your shipment, and aggressive agitation or warming risks degrading material while still leaving visible particulate. Researchers who buy dihexa routinely plan the solvent system before the vial arrives, then record solvent, concentration and preparation date alongside the lot number so results stay interpretable months later.

What if the vial arrives warm after several days in transit?

Document the excursion in writing and contact the supplier before opening anything. Lyophilized powder is considerably more tolerant of ambient temperature than a prepared solution, but tolerance is not immunity, and there is no home test that distinguishes intact from partially degraded peptidomimetic. A supplier that ships with disclosed cold-chain or insulated packaging and replaces compromised shipments is demonstrating the process control you paid for.

What if the supplier cannot produce a COA for my specific lot?

Treat the material as unidentified and do not use it in any experiment you intend to publish or repeat. A vendor that offers a generic, undated, or lot-free certificate is telling you it does not test per batch, which means purity and identity are assertions rather than measurements. Anyone who plans to buy dihexa more than once should request the lot-specific report before payment, not after delivery.

What if one vendor's price is a fraction of everyone else's?

Treat a dramatic outlier as a question about mass balance rather than a bargain. Underfilled vials, bulk material diluted with excipient, and outright substitution with a cheaper compound all produce exactly the pricing pattern you are looking at, and none of them are visible in a white lyophilized cake. Verified analytics, proper cold storage and per-batch testing are real costs, and a price that ignores them usually means someone skipped them.

The unglamorous truth about sourcing this compound

Here's the honest answer: there is no gold-standard, regulator-verified place to buy dihexa the way there is for an approved medicine, because no regulator stands behind any dihexa product anywhere. The entire market runs on supplier-provided analytics. Your confidence should therefore scale with the paperwork and nothing else: not site design, not review counts, not shipping speed. Research-grade dihexa is not a supplement, not a drug, and not for human or veterinary administration. If your question concerns an animal's health, talk to your veterinarian rather than sourcing a research chemical.

Our dihexa listing, with current fill weights and the analytical documentation attached to each batch, sits on the dihexa product page, and every lot we release is posted in the certificate of analysis library. Handling and identity questions are answered in the dihexa FAQ, the wider range of research compounds is in the full peptide catalog, and service and shipping coverage details are on our locations page. Researchers comparing options before they buy dihexa usually start with the COA library, which is the right instinct.

The decision to buy dihexa is, stripped of everything else, a decision about how much you trust a PDF. There is no pharmacy counter behind it, no monograph, no recall mechanism. What exists is a chromatogram, a lot number, and a supplier willing to be asked uncomfortable questions about both. Researchers who treat the certificate as the actual product, and the powder as the thing that certificate describes, tend to get reproducible work out of this compound. The ones who treat the vial as the product usually end up with a story about a peptide that did nothing.

Questions

Dihexa is sold by research-chemical and peptide supply companies as a lyophilized powder for research use only, and it is not stocked by pharmacies because it is not an approved drug product. The practical selection criteria are a lot-specific certificate of analysis, an HPLC chromatogram showing purity, mass spectrometry identity confirmation, and disclosed storage and shipping conditions. Suppliers that publish a searchable COA library per batch, rather than one reused document, are the easiest to verify.

No. Dihexa has no approved pharmaceutical formulation, so there is nothing for a prescriber to write and nothing for a pharmacy to dispense. The only legitimate channel is research supply, and every such product is labelled research use only and is not intended for human or veterinary administration.

Dihexa is generally handled as an unapproved research chemical rather than a controlled substance, and research-supply companies sell it on a research-use-only basis. Legal status and import rules vary by jurisdiction, so institutional buyers should confirm local requirements before ordering. What is clear everywhere is that it is not approved for human or veterinary use and cannot lawfully be marketed for consumption.

Pricing varies widely by fill weight, purity specification, and whether the supplier performs per-batch analytical testing, so a single figure would be misleading. Expect documented, small-batch material to cost noticeably more per milligram than bulk marketplace listings. A price far below every other supplier usually reflects a skipped cost such as per-lot testing, cold-chain shipping, or accurate fill weight.

A usable COA states the batch or lot number matching your vial label, the test date, the analytical methods used, an HPLC chromatogram supporting the stated purity, and a mass spectrometry result confirming molecular identity. Research-grade material is normally specified at 98% purity or higher. If the report has no lot number, no date, or no chromatogram, it is a marketing document rather than an analytical one.

Dihexa was designed to be highly lipophilic so it could cross the blood brain barrier in animal models, and that same property makes it poorly soluble in aqueous fluids. Bacteriostatic water works for hydrophilic peptides but leaves dihexa visibly undissolved. Laboratory workflows typically use an organic co-solvent such as DMSO or ethanol for stock preparation, with the solvent system recorded so results remain interpretable.

Lyophilized powder is kept sealed, dry, protected from light, and held at −20°C or colder for long-term stability. Prepared stock solutions are refrigerated at 2–8°C and split into single-use aliquots so the material is not subjected to repeated freeze-thaw cycles. Degraded peptidomimetic looks identical to intact material in the vial, which is why storage discipline matters more than visual inspection.

No. Dihexa is not an FDA-approved drug and there is no approved dihexa product for any indication in humans or animals. It is supplied as a research chemical, and the published work on it comes from preclinical laboratory and animal research rather than approved clinical use.

Conventional research peptides are hydrophilic chains that dissolve readily in aqueous solvent and are verified against a known amino-acid sequence. Dihexa is a lipophilic peptidomimetic, so it needs an organic co-solvent and its identity is confirmed by mass spectrometry rather than a straightforward sequence readout. That makes solvent documentation and analytical paperwork more decisive for dihexa than for a standard peptide of comparable purity.

The main risks are misidentified material, inaccurate fill weights, reused or fabricated certificates, and weeks of ambient-temperature transit with no documented cold chain. None of those failures are detectable by looking at a white lyophilized cake, so problems surface only as unexplained results later. If you cannot obtain a lot-specific analytical report tied to the vial you received, the material should be treated as unidentified.

Lyophilized dihexa tolerates short periods at ambient temperature better than a prepared solution does, but tolerance is not the same as stability, and long unrefrigerated transit is a real degradation risk. Suppliers that ship with insulated packaging, disclose their handling conditions, and replace compromised shipments are demonstrating process control. Any temperature excursion should be documented on arrival rather than assumed harmless.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA